Opinion
Optimizing Likelihood of Treatment for Postpartum Depression: Assessment of Barriers to Care
Screening and treatments are no longer barriers to care; access continues to be.
Opinion
Access to Perinatal Mental Healthcare: What Exactly Are The Obstacles?
Once screened, it can be very challenging to engage women with postpartum depression in treatment.
Opinion
Perinatal Psychiatry in 2024: Helping More Patients Access Care
Screening and identifying women who likely suffer from postpartum depression simply is not enough.
Opinion
Toward a better framework for postmarketing reproductive safety surveillance of medications
We want to empower patients to make decisions that work for them based on more rapidly accumulating information and help inform their decisions....
Opinion
Zuranolone: A novel postpartum depression treatment, with lingering questions
It is noteworthy that while zuranolone received FDA approval for the PPD indication, it did not receive approval for the treatment of major...
Opinion
Transcranial magnetic stimulation during pregnancy: An alternative to antidepressant treatment?
A growing number of women ask about nonpharmacologic approaches for either the treatment of acute perinatal depression or for relapse prevention...
Opinion
Canadian Task Force recommendation on screening for postpartum depression misses the mark
The task force recently recommended against screening with systematic questionnaires, noting that benefits were unclear and not a particular...
Opinion
Long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants: A look forward
Both antidepressants and newer mood stabilizers have been shown to be safe in pregnancy.
Opinion
Postpartum psychosis: Does longitudinal course inform treatment?
The good news is we’ve seen an evolution of both interest and expertise in acute management of postpartum psychosis and a richer appreciation of...
Opinion
Knowns and unknowns about SSRI use during pregnancy in 2022
Although some of the data remain incomplete, in 2022, patients will continue to make individual decisions factoring in the effect of maternal...
Opinion
Things reproductive psychiatrists might ‘always’ or ‘never’ do in 2022
In reproductive psychiatry, we tend to apply available data and clinical experience as we guide patients on a case-by-case basis.
News
Toward a clearer risk model for postpartum psychosis
Despite the growing, appropriate focus on recognition and acute treatment of postpartum depression as well as assessing clinical outcomes for...
Opinion
Reproductive safety of treatments for women with bipolar disorder
Women with bipolar disorder are at particular risk for postpartum worsening of their mood and we have noticed during the pandemic that women are...
Opinion
Reproductive psychiatry in 2021: Old questions and new challenges
The level of anxiety associated with decisions to sustain or to discontinue treatment during pregnancy seems to have increased for some patients...
Opinion
Treating insomnia, anxiety in a pandemic
We have unequivocally seen a worsening of complaints of sleep disruption including insomnia and midcycle awakening during the pandemic.